# Accro Bioscience funding: rounds and investors > Accro Bioscience has raised $64M across 2 rounds since 2025. Investors include Shenzhen Capital Group Co., Oriza Holdings and OrbiMed. Source: https://millionrounds.com/company/accro-bioscience (Millionrounds; every figure on the page links to its filing or article) China · [Series C startup](https://millionrounds.com/companies) # Who invested in *Accro Bioscience* 2 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Raised 6 months ago Follow Accro Bioscience and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fcompany%2Faccro-bioscience) Funding summary Updated 5 Nov 2026 **$64M** raised across 2 rounds since 2025, from 2 sources **$14M** Series B **$50M** Series C - **Latest round:** Series C, $50M May 2026 - **Led by:** OrbiMed - **Step-up i:** 3.6× - **Investors:** 9 (1 led) See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2026 **$14M** Series B **$50M** Series C - **First round:** Series B, $14M - **Biggest round:** $50M - **Between rounds:** 15 months ## The rounds - **May 2026** Series C **$50M** *4 new* *2 returning* [OrbiMed](https://millionrounds.com/fund/orbimed) Lead [Shenzhen Capital Group Co.](https://millionrounds.com/fund/shenzhen-capital-group) [Oriza Holdings](https://millionrounds.com/fund/oriza-holdings) [TCG Crossover](https://millionrounds.com/fund/tcg-crossover) [Cenova Capital](https://millionrounds.com/fund/cenova-capital) [LAV](https://millionrounds.com/fund/lav) Reported by Ventureburn - **Mar 2025** Series B **$14M** *5 new* [Shenzhen Capital Group Co.](https://millionrounds.com/fund/shenzhen-capital-group) [Morningside Group](https://millionrounds.com/fund/morningside) [5Y Capital](https://millionrounds.com/fund/5y-capital) [Oriza Holdings](https://millionrounds.com/fund/oriza-holdings) [GF Xinde Investment Management](https://millionrounds.com/fund/gf-xinde-investment-management) Source recorded ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series B** 2025 **Series C** 2026 [Shenzhen Capital Group Co.](https://millionrounds.com/fund/shenzhen-capital-group) [Oriza Holdings](https://millionrounds.com/fund/oriza-holdings) [OrbiMed](https://millionrounds.com/fund/orbimed) L [Morningside Group](https://millionrounds.com/fund/morningside) [5Y Capital](https://millionrounds.com/fund/5y-capital) [GF Xinde Investment Management](https://millionrounds.com/fund/gf-xinde-investment-management) [TCG Crossover](https://millionrounds.com/fund/tcg-crossover) [Cenova Capital](https://millionrounds.com/fund/cenova-capital) [LAV](https://millionrounds.com/fund/lav) ## Everyone who backed them [Shenzhen Capital Group Co.](https://millionrounds.com/fund/shenzhen-capital-group) Government **2** rounds [Oriza Holdings](https://millionrounds.com/fund/oriza-holdings) VC firm **2** rounds [OrbiMed](https://millionrounds.com/fund/orbimed) Private equity **1** round, led 1 [Morningside Group](https://millionrounds.com/fund/morningside) VC firm **1** round [5Y Capital](https://millionrounds.com/fund/5y-capital) VC firm **1** round [GF Xinde Investment Management](https://millionrounds.com/fund/gf-xinde-investment-management) VC firm **1** round [TCG Crossover](https://millionrounds.com/fund/tcg-crossover) VC firm **1** round [Cenova Capital](https://millionrounds.com/fund/cenova-capital) Growth equity **1** round [LAV](https://millionrounds.com/fund/lav) Growth equity **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=accro-bioscience). ## Quick answers about Accro Bioscience ### Who invested in Accro Bioscience? Accro Bioscience's investors include Shenzhen Capital Group Co., Oriza Holdings, OrbiMed, Morningside Group and 5Y Capital, and 4 more on record. OrbiMed led its latest round. ### How much has Accro Bioscience raised? Accro Bioscience has raised $64M across 2 rounds since 2025. ### When did Accro Bioscience last raise? Accro Bioscience's most recent round was a Series C of $50M in May 2026, led by OrbiMed. ### What was Accro Bioscience's biggest round? Its most recent round, $50M in May 2026, is also its largest on record. ### Who backed Accro Bioscience first? Accro Bioscience's first round on record, in Mar 2025, was backed by Shenzhen Capital Group Co., Morningside Group and 5Y Capital and 2 others. ### What stage is Accro Bioscience at? Accro Bioscience's latest named round is a Series C, in May 2026. ### Where is Accro Bioscience based? Accro Bioscience is based in China. ### Who led Accro Bioscience's rounds? OrbiMed led the Series C in 2026. ## Companies like Accro Bioscience In the same sector, and raised in the last eighteen months. [**BioGeometry** $100M · Oct 2026](https://millionrounds.com/company/biogeometry)[**Nutshell Therapeutics** $40M · Sept 2026](https://millionrounds.com/company/nutshell-therapeutics)[**RNAimmune** $4.5M · Aug 2026](https://millionrounds.com/company/rnaimmune)[**Gestala** $22M · Mar 2026](https://millionrounds.com/company/gestala)[**Adlai Nortye** $190M · Feb 2026](https://millionrounds.com/company/adlai-nortye)[**HitGen** $39M · Nov 2025](https://millionrounds.com/company/hitgen) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app